Isolation and characterization of a potentially novel Siphoviridae phage (vB_SsapS-104) with lytic activity against Staphylococcus saprophyticus isolated from urinary tract infection.


Journal

Folia microbiologica
ISSN: 1874-9356
Titre abrégé: Folia Microbiol (Praha)
Pays: United States
ID NLM: 0376757

Informations de publication

Date de publication:
May 2019
Historique:
received: 13 02 2018
accepted: 25 09 2018
pubmed: 5 10 2018
medline: 19 9 2019
entrez: 5 10 2018
Statut: ppublish

Résumé

Antibiotic resistance is increasing among Staphylococcus saprophyticus strains isolated from urinary tract infection. This necessitates alternative therapies. For this, a lytic phage (vB_SsapS-104) against S. saprophyticus, which formed round and clear plaques on bacterial culture plates, was isolated from hospital wastewater and characterized. Microscopy analysis showed that it had a small head (about 50 nm), tail (about 80 nm), and a collar (about 22 nm in length and 19 nm in width) indicating to be a phage within Siphoviridae family. Phage vB_SsapS-104 showed a large latency period of about 40 min, rapid adsorption rate that was significantly enhanced by MgCl

Identifiants

pubmed: 30284669
doi: 10.1007/s12223-018-0653-9
pii: 10.1007/s12223-018-0653-9
doi:

Substances chimiques

Anti-Bacterial Agents 0
DNA, Viral 0
Waste Water 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-294

Subventions

Organisme : Golestan University of Medical Sciences
ID : 35/219525

Références

Antimicrob Agents Chemother. 2001 Mar;45(3):649-59
pubmed: 11181338
Appl Environ Microbiol. 2005 Apr;71(4):1836-42
pubmed: 15812009
J Clin Microbiol. 2005 Jul;43(7):3390-7
pubmed: 16000464
J Infect Chemother. 2005 Oct;11(5):211-9
pubmed: 16258815
Lett Appl Microbiol. 2005;41(6):482-6
pubmed: 16305674
Antimicrob Agents Chemother. 2006 Apr;50(4):1268-75
pubmed: 16569839
J Clin Microbiol. 2007 May;45(5):1561-4
pubmed: 17344356
Lett Appl Microbiol. 2007 Sep;45(3):313-7
pubmed: 17718845
Obstet Gynecol Clin North Am. 2008 Jun;35(2):235-48, viii
pubmed: 18486839
Appl Environ Microbiol. 2009 Jul;75(13):4483-90
pubmed: 19411410
Environ Microbiol. 2009 Nov;11(11):2775-7
pubmed: 19519870
Curr Pharm Biotechnol. 2010 Jan;11(1):69-86
pubmed: 20214609
BMC Microbiol. 2010 Apr 29;10:131
pubmed: 20426877
FEMS Immunol Med Microbiol. 2010 Aug;59(3):447-55
pubmed: 20528927
Int J Microbiol. 2010;2010:null
pubmed: 20862383
Appl Environ Microbiol. 2011 Feb;77(3):756-61
pubmed: 21148689
Res Virol. 1990 Nov-Dec;141(6):625-35
pubmed: 2150893
Arch Virol. 2012 Feb;157(2):225-34
pubmed: 22045271
Bacteriophage. 2011 Mar;1(2):66-85
pubmed: 22334863
BMC Genomics. 2012 Jun 08;13:228
pubmed: 22681775
Adv Virus Res. 2012;83:143-216
pubmed: 22748811
Future Microbiol. 2012 Oct;7(10):1147-71
pubmed: 23030422
PLoS One. 2012;7(10):e46537
pubmed: 23071586
Viruses. 2012 Dec;4(12):3316-35
pubmed: 23342361
Virulence. 2014 Jan 1;5(1):226-35
pubmed: 23973944
Arch Virol. 2014 Sep;159(9):2537-40
pubmed: 24777828
Arch Virol. 2014 Nov;159(11):2909-15
pubmed: 24928734
Mol Biol Rep. 2014 Sep;41(9):5829-38
pubmed: 24981924
J Med Microbiol. 2015 Apr;64(Pt 4):454-62
pubmed: 25681321
Bacteriophage. 2016 Aug 5;6(3):e1219440
pubmed: 27738555
Virus Genes. 2017 Jun;53(3):464-476
pubmed: 28299517
Ann Intern Med. 1985 Mar;102(3):342-3
pubmed: 3871598
Res Virol. 1994 Mar-Apr;145(2):111-21
pubmed: 8059065
Eur J Epidemiol. 1996 Feb;12(1):51-4
pubmed: 8817178
Adv Virus Res. 1998;51:135-201
pubmed: 9891587

Auteurs

Mahsa Yazdi (M)

Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, 81746-73441, Iran.

Majid Bouzari (M)

Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, 81746-73441, Iran. bouzari@sci.ui.ac.ir.

Ezzat Allah Ghaemi (EA)

Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, 4934174515, Iran.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH